Track the 바디텍메드 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 바디텍메드 has published 21 insider filings. Market capitalisation: €226bn. The latest transaction was reported on 7 April 2026 (Other). Among the most active insiders: 박대균. All data is openly available.
21
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
2 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,162 of 26,211 companies
69.4
score / 100
Value
63
Quality
76
FCF yld-4.8%
Earn yld9.6%
EV/EBITDA6.9x
ROE11%
Gross mgn59%
Net mgn15%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.